HOUSTON, Sept. 23, 2020 /PRNewswire/ — Pharm-Olam International, a global mid-sized clinical research organization (CRO), has been selected by the U.S. Department of Defense (DOD) to build capability at military treatment facilities in order to support Phase III clinical trials of…
J&J’s One-Dose COVID-19 Vaccine Candidate Begins Phase III Trial
In the U.S., most of the attention to the COVID-19 vaccine race has been on Moderna, Pfizer and BioNTech, and AstraZeneca and the University of Oxford, which are leading the way. There are a number of other major biopharma companies…
Novavax Begin Phase III Study of COVID-19 Vaccine Candidate in the U.K.
Maryland’s Novavax initiated a Phase III study of its COVID-19 vaccine candidate in the United Kingdom. The late-stage study is part of an agreementstruck between the company and the U.K. government last month that includes providing 60 million doses of…
Rs 25,000 crore plan to cut dependence on China for key chemicals
NEW DELHI: With the aim to reduce dependence on China for import of chemicals, the government is planning a production linked incentive scheme to boost local manufacturing of some of the key chemicals used in pharmaceuticals, insecticides and in other…
OPKO Health evaluates Rayaldee to treat Covid-19 patients
Biopharmaceutical company OPKO Health has launched a Phase II clinical trial to assess Rayaldee as a potential treatment for mild to moderate Covid-19. The drug is an extended-release oral formulation of calcifediol, a prohormone of calcitriol, the active form of…
Lilly reports Covid-19 antibody reduced rate of hospitalisation
Eli Lilly has reported positive proof-of-concept results from the BLAZE-1 clinical trial, which assessed SARS-CoV-2 neutralising antibody candidate LY-CoV555, to treat symptomatic Covid-19 in outpatients. An interim analysis found that the drug candidate decreased rate of hospitalisation. The study involved…
Vaxart secures FDA clearance to trial Covid-19 vaccine candidate
Biotechnology firm Vaxart has received clearance from the US Food and Drug Administration (FDA) to conduct a Phase I clinical trial of its Covid-19 vaccine candidate. The company is developing an oral vaccine to prevent Covid-19. Based on the company’s…
Imperial College team to assess inhaled Covid-19 vaccines
Imperial College London is set to conduct small clinical trials of inhaled versions of Covid-19 vaccines developed by researchers and the University of Oxford. The trials, funded by UKRI-NIHR, will test the safety and efficacy of giving the vaccines as…
AstraZeneca CEO Says COVID-19 Vaccine Trial Pause is the Second Since July
In a private call with investors from J.P. Morgan late Wednesday, AstraZeneca Chief Executive Officer Pascal Soriot confirmed that a woman injected with the company’s experimental COVID-19 vaccine candidate developed a serious spinal inflammatory disorder called transverse myelitis. The trial…
DCGI issues notice to HUL over misleading covid fighting hand sanitiser advertisement
The advertising campaign and packaging of the HUL-owned hygiene product, claiming an immunity boosting effect, are misleading and false as a topical application product. NEW DELHI : The Drug Controller General of India (DCGI) V G Somani has issued a…
